Oak Associates’s Cigna CI Stock Holding History

Oak Associates’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.7M	Hold	47,770	–	–	0.86%	31
2025 Q4	$13.1M	Buy	47,770 +598	+1%	+$168K	0.79%	35
2025 Q3	$13.6M	Sell	47,172 -1,481	-3%	-$438K	0.83%	31
2025 Q2	$16.1M	Buy	48,653 +2,175	+5%	+$701K	1.05%	28
2025 Q1	$15.3M	Buy	46,478 +132	+0.3%	+$39.8K	1.15%	26
2024 Q4	$12.8M	Buy	46,346 +2	+0%	+$638	0.88%	30
2024 Q3	$16.1M	Buy	46,344 +1,393	+3%	+$480K	1.08%	28
2024 Q2	$14.9M	Buy	44,951 +150	+0.3%	+$51.7K	0.99%	26
2024 Q1	$16.3M	Hold	44,801	–	–	1.13%	26
2023 Q4	$13.4M	Buy	44,801 +701	+2%	+$205K	1.01%	29
2023 Q3	$12.6M	Buy	44,100 +4,508	+11%	+$1.29M	1.05%	29
2023 Q2	$11.1M	Sell	39,592 -5	-0%	-$1.3K	0.89%	34
2023 Q1	$10.1M	Sell	39,597 -4,488	-10%	-$1.31M	0.83%	37
2022 Q4	$14.6M	Buy	44,085 +32,952	+296%	+$10.4M	1.23%	26
2022 Q3	$3.09M	Buy	11,133 +136	+1%	+$38.3K	0.26%	57
2022 Q2	$2.9M	Sell	10,997 -1,495	-12%	-$385K	0.23%	61
2022 Q1	$2.99M	Hold	12,492	–	–	0.18%	63
2021 Q4	$2.87M	Sell	12,492 -50	-0.4%	-$10.6K	0.15%	69
2021 Q3	$2.51M	Hold	12,542	–	–	0.14%	70
2021 Q2	$2.97M	Sell	12,542 -32	-0.3%	-$7.99K	0.17%	67
2021 Q1	$3.04M	Sell	12,574 -2,656	-17%	-$592K	0.18%	63
2020 Q4	$3.17M	Sell	15,230 -48,920	-76%	-$9.59M	0.19%	62
2020 Q3	$10.9M	Sell	64,150 -45	-0.1%	-$7.92K	0.73%	39
2020 Q2	$12M	Hold	64,195	–	–	0.81%	37
2020 Q1	$11.4M	Hold	64,195	–	–	0.93%	33
2019 Q4	$13.1M	Sell	64,195 -500	-0.8%	-$91.7K	0.77%	41
2019 Q3	$9.82M	Sell	64,695 -365	-0.6%	-$59.4K	0.61%	49
2019 Q2	$10.3M	Sell	65,060 -3,445	-5%	-$540K	0.64%	46
2019 Q1	$11M	Buy	68,505 +19,500	+40%	+$3.56M	0.67%	43
2018 Q4	$9.31M	Buy	49,005 +35,005	+250%	+$7.3M	0.66%	45
2018 Q3	$2.92M	Hold	14,000	–	–	0.18%	81
2018 Q2	$2.38M	Hold	14,000	–	–	0.16%	83
2018 Q1	$2.35M	Hold	14,000	–	–	0.16%	83
2017 Q4	$2.84M	Hold	14,000	–	–	0.2%	77
2017 Q3	$2.62M	Hold	14,000	–	–	0.19%	86
2017 Q2	$2.34M	Hold	14,000	–	–	0.18%	93
2017 Q1	$2.05M	Hold	14,000	–	–	0.16%	97
2016 Q4	$1.87M	Hold	14,000	–	–	0.18%	97
2016 Q3	$1.66M	Sell	14,000 -4,200	-23%	-$548K	0.17%	100
2016 Q2	$2.33M	Hold	18,200	–	–	0.28%	84
2016 Q1	$2.5M	Hold	18,200	–	–	0.31%	75
2015 Q4	$2.66M	Hold	18,200	–	–	0.32%	74
2015 Q3	$2.46M	Hold	18,200	–	–	0.33%	72
2015 Q2	$2.95M	Hold	18,200	–	–	0.36%	64
2015 Q1	$2.36M	Hold	18,200	–	–	0.28%	80
2014 Q4	$1.87M	Hold	18,200	–	–	0.22%	90
2014 Q3	$1.65M	Buy	+18,200	New	+$1.7M	0.2%	95

Other funds holding CI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Oak Associates's CI Position: Q1 2026 in Review

Oak Associates held its Cigna (CI) position steady in Q1 2026 at 47,770 shares worth $12.7M. The position accounts for 0.86% of the portfolio, ranked #31.

Oak Associates first reported a position in CI in Q3 2014 and has held it in 47 quarters since. The position peaked at $16.3M in Q1 2024. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.

Oak Associates held 47,770 shares of Cigna worth $12.7M as of Q1 2026.
Oak Associates left its Cigna share count unchanged in Q1 2026.
Cigna made up 0.86% of Oak Associates's portfolio in Q1 2026, its #31 holding.
Oak Associates first reported a position in Cigna in Q3 2014 and has held it in 47 quarters since.
Oak Associates's Cigna position peaked at $16.3M in Q1 2024.
1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Oak Associates's 13F filing for Q1 2026, filed 14 May 2026.